Pharmacogenomics : Impact Factor & More
eISSN: 1744-8042pISSN: 1462-2416
Share this on:
Key Metrics
CiteScore 
3.6
H-Index
97
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.64
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pharmacogenomics
Pharmacogenomics Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacogenomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmacogenomics
U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole.
- 3 Aug 2026
- Pharmacogenomics
Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan.
- 31 Jul 2026
- Pharmacogenomics
Impact of NAT2 acetylation phenotype on toxicity in tuberculosis therapy: a systematic review and meta-analysis.
- 30 Jul 2026
- Pharmacogenomics
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.
- 22 Jul 2026
- Pharmacogenomics
Genetics of tardive dyskinesia: a review of progress over the past decade.
- 18 May 2026
- Pharmacogenomics
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer.
- 19 Apr 2026
- Pharmacogenomics
U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole.
- 3 Aug 2026
- Pharmacogenomics
Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan.
- 31 Jul 2026
- Pharmacogenomics
Impact of NAT2 acetylation phenotype on toxicity in tuberculosis therapy: a systematic review and meta-analysis.
- 30 Jul 2026
- Pharmacogenomics
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.
- 22 Jul 2026
- Pharmacogenomics
Genetics of tardive dyskinesia: a review of progress over the past decade.
- 18 May 2026
- Pharmacogenomics
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer.
- 19 Apr 2026
- Pharmacogenomics
FAQs on Pharmacogenomics
How long has Pharmacogenomics been actively publishing? 
What is the publishing frequency of Pharmacogenomics?
How many articles did Pharmacogenomics publish last year?
What is the eISSN & pISSN for Pharmacogenomics?
What is Citescore for Pharmacogenomics?
What is the H Index for Pharmacogenomics ?
What is SNIP score for Pharmacogenomics?
What is the SJR for Pharmacogenomics?
Who is the publisher of Pharmacogenomics?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations